CAS 500363-63-3

NSC117079

CAS : 500363-63-3

NSC117079

Degré de pureté : ≥98%

Masse moléculaire : 473.48g/mol

Ref: 54-BUP21284

NSC 117079

CAS : 500363-63-3

NSC 117079 is a small molecule that binds to the influenza virus and inhibits its ability to invade cells. It also inhibits the activity of human endometrial phosphatase and has been shown to have a potential biomarker for cancer. NSC 117079 is an inhibitor of protein synthesis, which is due to its effect on phosphatases in cells. This drug has been shown to inhibit osteoarthritic cartilage degradation by inhibiting the enzyme cathepsin K and has shown efficacy in studies involving mice with meniscus damage. The pharmacokinetic properties of NSC 117079 are not well-known, but it has been found to be stable in vivo.

Formule : C₂₀H₁₅N₃O₇S₂

Degré de pureté : Min. 95%

Masse moléculaire : 473.48 g/mol

Ref: 3D-AVA36363

NSC117079

CAS : 500363-63-3

NSC117079 is a novel PHLPP1/2 (Pleckstrin homology domain and leucine rich repeat protein phosphatase) inhibitor that activates neuronal AKT .

Formule : C₂₀H₁₅N₃O₇S₂

Degré de pureté : 98.11%

Couleur et forme : Solid

Masse moléculaire : 473.48

Ref: TM-T12260